Guided by an external magnetic field to enhance tumor-site accumulation, this strategy significantly augmented PD-L1 blockade and promoted CTL activation in melanoma-bearing mice, extending median survival from 32 to 63 days. The gene discussed is CD274; the disease is melanoma.